tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Simcere’s ENZESHU® and ENDOSTAR® Included in China’s National Reimbursement Drug List
PremiumCompany AnnouncementsSimcere’s ENZESHU® and ENDOSTAR® Included in China’s National Reimbursement Drug List
3M ago
Simcere Secures Exclusive License for Deuterated Remdesivir Hydrobromide
Premium
Company Announcements
Simcere Secures Exclusive License for Deuterated Remdesivir Hydrobromide
3M ago
Simcere Pharmaceutical Grants 15.4 Million RSUs to Key Personnel
Premium
Company Announcements
Simcere Pharmaceutical Grants 15.4 Million RSUs to Key Personnel
3M ago
Simcere’s Pediatric Anti-Influenza Drug Gains Regulatory Nod
PremiumCompany AnnouncementsSimcere’s Pediatric Anti-Influenza Drug Gains Regulatory Nod
6M ago
Simcere Pharmaceutical Announces Share Placing and Subscription Agreement
Premium
Company Announcements
Simcere Pharmaceutical Announces Share Placing and Subscription Agreement
6M ago
Simcere Pharmaceutical Expands with Strategic Acquisitions
Premium
Company Announcements
Simcere Pharmaceutical Expands with Strategic Acquisitions
6M ago
Simcere Pharmaceutical Schedules Board Meeting to Review Interim Results
PremiumCompany AnnouncementsSimcere Pharmaceutical Schedules Board Meeting to Review Interim Results
7M ago
Simcere’s Rademikibart NDA Accepted by China’s NMPA
Premium
Company Announcements
Simcere’s Rademikibart NDA Accepted by China’s NMPA
8M ago
Simcere’s ENZESHU® Gains Approval in China for Platinum-Resistant Ovarian Cancer
Premium
Company Announcements
Simcere’s ENZESHU® Gains Approval in China for Platinum-Resistant Ovarian Cancer
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100